BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22777296)

  • 21. Growth hormone therapy in Noonan syndrome: growth response and characteristics.
    Westphal O
    Horm Res; 2009 Dec; 72 Suppl 2():41-5. PubMed ID: 20029236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inside the Noonan "universe": Literature review on growth, GH/IGF axis and rhGH treatment: Facts and concerns.
    Stagi S; Ferrari V; Ferrari M; Priolo M; Tartaglia M
    Front Endocrinol (Lausanne); 2022; 13():951331. PubMed ID: 36060964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth in Children With Noonan Syndrome and Effects of Growth Hormone Treatment on Adult Height.
    Libraro A; D'Ascanio V; Cappa M; Chiarito M; Digilio MC; Einaudi S; Grandone A; Maghnie M; Mazzanti L; Mussa A; Patti G; Scarano E; Spinuzza A; Vannelli S; Wasniewska MG; Ferrero GB; Faienza MF
    Front Endocrinol (Lausanne); 2021; 12():761171. PubMed ID: 35002956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Growth Characteristics of Patients with Noonan Syndrome: Results of Three Years of Growth Hormone Treatment: A Nationwide Multicenter Study.
    Şıklar Z; Genens M; Poyrazoğlu Ş; Baş F; Darendeliler F; Bundak R; Aycan Z; Savaş Erdeve Ş; Çetinkaya S; Güven A; Abalı S; Atay Z; Turan S; Kara C; Can Yılmaz G; Akyürek N; Abacı A; Çelmeli G; Sarı E; Bolu S; Korkmaz HA; Şimşek E; Çatlı G; Büyükinan M; Çayır A; Evliyaoğlu O; İşgüven P; Özgen T; Hatipoğlu N; Elhan AH; Berberoğlu M
    J Clin Res Pediatr Endocrinol; 2016 Sep; 8(3):305-12. PubMed ID: 27125300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of recombinant human growth hormone for 1 year on body composition and muscle strength in children on long-term steroid therapy: randomized controlled, delayed-start study.
    Simon D; Alberti C; Alison M; Le Henaff L; Chevenne D; Boizeau P; Canal A; Ollivier G; Decostre V; Jacqz-Aigrain E; Carel JC; Czernichow P; Hogrel JY
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2746-54. PubMed ID: 23626006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children.
    Binder G; Baur F; Schweizer R; Ranke MB
    J Clin Endocrinol Metab; 2006 Feb; 91(2):659-64. PubMed ID: 16291706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Excellent growth response to growth hormone therapy in a child with PTPN11-negative Noonan syndrome and features of growth hormone resistance.
    Walton-Betancourth S; Martinelli CE; Thalange NK; Dyke MP; Acerini CL; White S; Camacho-Hübner C; Savage MO
    J Endocrinol Invest; 2007 May; 30(5):439-41. PubMed ID: 17598979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant human growth hormone plus recombinant human insulin-like growth factor-1 coadministration therapy in short children with low insulin-like growth factor-1 and growth hormone sufficiency: results from a randomized, multicenter, open-label, parallel-group, active treatment-controlled trial.
    Backeljauw PF; Miller BS; Dutailly P; Houchard A; Lawson E; Hale DE; Reiner B; Sperling MA;
    Horm Res Paediatr; 2015; 83(4):268-79. PubMed ID: 25765099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutational analysis of the PTPN11 gene in Egyptian patients with Noonan syndrome.
    Essawi ML; Ismail MF; Afifi HH; Kobesiy MM; El Kotoury A; Barakat MM
    J Formos Med Assoc; 2013 Nov; 112(11):707-12. PubMed ID: 24183200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Genetic identification of a case of Noonan syndrome and treatment with growth hormone].
    Pi G; Zúñiga A; Gastaldo E; Ortiz M
    Med Clin (Barc); 2014 Apr; 142(8):378-9. PubMed ID: 24054841
    [No Abstract]   [Full Text] [Related]  

  • 31. The association between growth response to growth hormone and baseline body composition of children with growth hormone deficiency.
    Esen I; Demirel F; Tepe D; Kara O; Koc N
    Growth Horm IGF Res; 2013 Oct; 23(5):196-9. PubMed ID: 23890535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of growth hormone therapy on adult height in noonan syndrome: a systematic review.
    Giacomozzi C; Deodati A; Shaikh MG; Ahmed SF; Cianfarani S
    Horm Res Paediatr; 2015; 83(3):167-76. PubMed ID: 25721697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical features, genetic detection and therapeutic response to rhGH of children with Noonan syndrome: an analysis of 12 cases.
    Shangguan H; Xu Y; Chen R
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 50(4):500-505. PubMed ID: 34704406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The efficacy and safety of growth hormone therapy in children with noonan syndrome: a review of the evidence.
    Noonan JA; Kappelgaard AM
    Horm Res Paediatr; 2015; 83(3):157-66. PubMed ID: 25503994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hotspots in PTPN11 Gene Among Indian Children With Noonan Syndrome.
    Narayanan DL; Pandey H; Moirangthem A; Mandal K; Gupta R; Puri RD; Patil SJ; Phadke SR
    Indian Pediatr; 2017 Aug; 54(8):638-643. PubMed ID: 28607217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth patterns of patients with Noonan syndrome: correlation with age and genotype.
    Cessans C; Ehlinger V; Arnaud C; Yart A; Capri Y; Barat P; Cammas B; Lacombe D; Coutant R; David A; Baron S; Weill J; Leheup B; Nicolino M; Salles JP; Verloes A; Tauber M; Cavé H; Edouard T
    Eur J Endocrinol; 2016 May; 174(5):641-50. PubMed ID: 26903553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between exon 3 polymorphism of growth hormone receptor gene and the responses to rhGH therapy.
    Wei Y; Zheng R; Zhou Y; Wang J; Bao P
    Int J Clin Exp Pathol; 2015; 8(6):7371-7. PubMed ID: 26261638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Occurrence of DNET and other brain tumors in Noonan syndrome warrants caution with growth hormone therapy.
    McWilliams GD; SantaCruz K; Hart B; Clericuzio C
    Am J Med Genet A; 2016 Jan; 170A(1):195-201. PubMed ID: 26377682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Noonan syndrome, the Ras-MAPK signalling pathway and short stature.
    Binder G
    Horm Res; 2009 Apr; 71 Suppl 2():64-70. PubMed ID: 19407499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between vitamin D receptor (VDR) polymorphisms and the efficacy of recombinant human growth hormone (rhGH) treatment in children with idiopathic short stature.
    Wang W; Luo XP; Cai LX; Cui ZR; Luo XY; Luo RK
    Genet Mol Res; 2015 Sep; 14(3):10507-14. PubMed ID: 26400282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.